Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Washington Post: Seldane to be taken off U.S. market by its maker. 30 December 1997. (https://www.washingtonpost.com/archive/politics/1997/12/30/seldane-to-be-taken-off-us-market-by-maker/69d37826-3c40-49b1-8167-06c9c8b191b0/)
2. Pratt C, Brown AM, Rampe D, Mason J, Russell T, Reynolds R, Ahlbrandt R (1999) Cardiovascular safety of fexofenadine HCl. Clin & Exper Allergy 29:212–216
3. Sheiner LB, Lewis B, Rosenberg B, Marathe VV (1980) Evaluation of methods for estimating population pharmacokinetic parameters I. Michaelis-Menten model: routine clinical pharmacokinetic data". J Pharmacokin Biopharm 8:553–571
4. Sheiner LB, Beal SL (1981) Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data. J Pharmacokin Biopharm 9:635–651
5. Routine clinical pharmacokinetic data (1983) Sheiner LB and Beal SL. "Evaluation of Methods for Estimating Population Pharmacokinetic Parameters III. Monoexponential model. J Pharmacokin Biopharm 11:303–319
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Correction to: QTc interval analysis—an ever-evolving endeavor;Journal of Pharmacokinetics and Pharmacodynamics;2021-04-22